Historical Stock Price
ETFs Holding BMY »    BMY Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
01/19/2023 $72.35 $73.87 $72.16 $73.75 9.39M
01/20/2023 $73.90 $74.15 $73.35 $74.15 10.52M
01/23/2023 $74.09 $74.20 $72.85 $73.26 7.43M
01/24/2023 $73.00 $75.00 $72.12 $72.34 7.30M
01/25/2023 $72.56 $73.24 $72.01 $73.17 6.64M
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
BMY historical stock prices picture
Bristol Myers Squibb (BMY) has the following price history information. Looking back at BMY historical stock prices for the last five trading days, on January 19, 2023, BMY opened at $72.35, traded as high as $73.87 and as low as $72.16, and closed at $73.75. Trading volume was a total of 9.39M shares. On January 20, 2023, BMY opened at $73.90, traded as high as $74.15 and as low as $73.35, and closed at $74.15. Trading volume was a total of 10.52M shares. On January 23, 2023, BMY opened at $74.09, traded as high as $74.20 and as low as $72.85, and closed at $73.26. Trading volume was a total of 7.43M shares. On January 24, 2023, BMY opened at $73.00, traded as high as $75.00 and as low as $72.12, and closed at $72.34. Trading volume was a total of 7.30M shares. On January 25, 2023, BMY opened at $72.56, traded as high as $73.24 and as low as $72.01, and closed at $73.17. Trading volume was a total of 6.64M shares.

BMY Historical Stock Prices By Date:

BMY historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bristol Myers Squibb shares, starting with a $10,000 purchase of BMY, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 01/29/2013
End date: 01/25/2023
Start price/share: $36.54
End price/share: $73.17
Starting shares: 273.67
Ending shares: 364.83
Dividends reinvested/share: $16.78
Total return: 166.94%
Average Annual Total Return: 10.32%
Starting investment: $10,000.00
Ending investment: $26,687.56
Years: 9.99
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/29/2013
End date: 01/25/2023
Start price/share: $36.54
End price/share: $73.17
Dividends collected/share: $16.78
Total return: 146.17%
Average Annual Total Return: 9.43%
Starting investment: $10,000.00
Ending investment: $24,612.15
Years: 9.99
Date Close
01/19/2023$73.75
01/20/2023$74.15
01/23/2023$73.26
01/24/2023$72.34
01/25/2023$73.17
BMY is categorized under the Healthcare sector; below are some other companies in the same sector:

BNC Historical Stock Prices
BOLD Historical Stock Prices
BONE Historical Stock Prices
BOT Historical Stock Prices
BOTA Historical Stock Prices
BPAX Historical Stock Prices
BPMC Historical Stock Prices
BPMX Historical Stock Prices
BPTH Historical Stock Prices
BRKR Historical Stock Prices

Also explore: BMY shares outstanding history

Email EnvelopeFree BMY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

BMY Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.